Vertex Pharmaceuticals (VRTX) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vertex Pharmaceuticals

    NASDAQ: VRTX · Real-Time Price · USD
    396.12
    -0.81 (-0.20%)
    At close: Sep 05, 2025, 3:59 PM
    396.00
    -0.03%
    After-hours: Sep 05, 2025, 07:31 PM EDT

    Vertex Pharmaceuticals Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
    ALYFTREK Revenue 156.8M 53.9M 594.6M 186.9M 2.45B 2.48B 2.33B 2.27B 2.24B 2.1B 2.02B 2.01B 1.89B 1.76B 1.69B 1.56B 1.26B 1.19B 1.09B 960.31M 917.72M 895.23M 420.11M
    ALYFTREK Revenue Growth +190.91% -90.94% +218.14% -92.37% -1.39% +6.44% +2.59% +1.51% +6.85% +3.72% +0.55% +6.20% +7.47% +4.08% +8.79% +23.91% +5.23% +9.41% +13.56% +4.64% +2.51% +113.10% n/a
    Manufactured Product, Other Revenue 236.1M 170.8M 2.72B 2.58B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Manufactured Product, Other Revenue Growth +38.23% -93.72% +5.25% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    TRIKAFTA-KAFTRIO Revenue 2.55B 2.54B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    TRIKAFTA-KAFTRIO Revenue Growth +0.62% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Revenue by Geography

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
    Europe Revenue 910.9M 826.6M 832M 847.7M 806.8M 967.4M 735.3M 766.5M 800M 807.2M 687.2M 730.5M 655.5M 632.3M 590.2M 518.83M 458.91M 404.97M 360.02M 251.37M 257.68M 257.39M 352.97M 184.84M 180.2M 167.75M 142.49M 132.88M 135.91M 131.9M
    Europe Revenue Growth +10.20% -0.65% -1.85% +5.07% -16.60% +31.57% -4.07% -4.19% -0.89% +17.46% -5.93% +11.44% +3.67% +7.13% +13.76% +13.06% +13.32% +12.48% +43.23% -2.45% +0.11% -27.08% +90.95% +2.58% +7.42% +17.72% +7.24% -2.24% +3.05% n/a
    United States Revenue 1.83B 1.65B 1.84B 210.7M 224.5M 203.3M 1.57B 162.8M 185.4M 163.8M 1.46B 148.2M 125.6M 97M 1.39B 82.45M 77.54M 64.9M 1.21B 62.34M 56.49M 70.13M 1.01B 710.32M 700.62M 641.1M 677.12M 620.49M 584.81M 482.67M
    United States Revenue Growth +10.52% -10.00% +771.95% -6.15% +10.43% -87.09% +867.20% -12.19% +13.19% -88.78% +885.43% +17.99% +29.48% -93.04% +1590.87% +6.32% +19.48% -94.62% +1835.86% +10.36% -19.45% -93.06% +42.26% +1.39% +9.28% -5.32% +9.13% +6.10% +21.16% n/a
    Other, Non U.S. Revenue 205.6M 280.1M 242.8M 1.71B 1.61B 1.52B 207.8M 1.55B 1.51B 1.4B 155.1M 1.46B 1.42B 1.37B 88.31M 1.38B 1.26B 1.25B 60.94M 1.22B 1.21B 1.19B n/a n/a n/a n/a n/a n/a n/a n/a
    Other, Non U.S. Revenue Growth -26.60% +15.36% -85.83% +6.15% +6.21% +631.42% -86.63% +3.08% +7.41% +805.09% -89.34% +2.86% +3.43% +1449.37% -93.61% +10.02% +0.28% +1956.76% -95.02% +1.18% +1.91% n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 424.6M 396.4M 377.6M 371.8M 372.2M 342.7M 369.1M 263.8M 262.6M 241.1M 267.4M 246.8M 215.3M 215.2M 255.2M 198.19M 194.6M 192.08M 211.84M 184.55M 191.8M 182.26M 195.28M 159.67M 156.5M 147.04M 153.21M 137.29M 137.3M 129.81M 134.79M 120.71M 127.25M 113.33M 109.91M 106.06M 111.65M 105.21M 97.05M 99.77M 94.39M 85.86M
    Selling, General, and Administrative Revenue Growth +7.11% +4.98% +1.56% -0.11% +8.61% -7.15% +39.92% +0.46% +8.92% -9.84% +8.35% +14.63% +0.05% -15.67% +28.77% +1.84% +1.31% -9.33% +14.79% -3.78% +5.24% -6.67% +22.30% +2.03% +6.43% -4.02% +11.59% -0.01% +5.77% -3.70% +11.67% -5.14% +12.29% +3.11% +3.63% -5.01% +6.12% +8.41% -2.72% +5.70% +9.94% n/a
    Research and Development Revenue 978.4M 979.7M 998.7M 875.9M 5.42B 865.9M 1.35B 861.7M 896.2M 742.6M 694.1M 645M 600.1M 603.1M 694.3M 493.75M 1.41B 455.97M 466.58M 493.5M 420.93M 448.53M 480.01M 555.95M 379.09M 339.49M 437.88M 330.51M 337.53M 310.55M 306.66M 454.95M 289.45M 273.56M 248.45M 275.37M 271.01M 255.86M 310.43M 246.28M 223.86M 215.6M
    Research and Development Revenue Growth -0.13% -1.90% +14.02% -83.83% +525.44% -35.94% +56.86% -3.85% +20.68% +6.99% +7.61% +7.48% -0.50% -13.14% +40.62% -64.91% +208.59% -2.27% -5.45% +17.24% -6.15% -6.56% -13.66% +46.65% +11.66% -22.47% +32.49% -2.08% +8.69% +1.27% -32.59% +57.18% +5.81% +10.11% -9.78% +1.61% +5.92% -17.58% +26.05% +10.02% +3.83% n/a

    Add to Watchlist